Mission: HPV Cancer-Free Illinois Roundtable (free event with CEUs)

Posted over 2 years ago by Erin O'donohue

Join EverThrive Illinois, Chicago Department of Public Health, University of Chicago Medicine, the American Cancer Society and other partners for a day-long roundtable. This event will explore how health care providers, patient advocates, policymakers, and allied health professionals can work together to increase HPV vaccination rates across the state.

Mission: HPV Cancer Free | Illinois Roundtable
Thursday, November 15
8:00 a.m. - 5:00 p.m.

Malcolm X College
900 W Jackson Blvd
Chicago, IL 60612

REGISTER HEREhttps://www.everthriveil.org/event/mission-hpv-cancer-free-illinois-roundtable

Registration is available for both morning and afternoon sessions, and all-day. The event is free, please register by Friday, November 9. Breakfast and lunch will be provided during the morning session.

We are pleased to welcome Dr. Melinda Wharton, the Director of the Immunization Services Division at the Centers for Disease Control and Prevention. For a full list of presenters and speakers, please visit the event webpage here.


Morning Session

8:00 a.m. - 8:30 a.m. - Registration & breakfast 
8:30 a.m. - 12:00 p.m.- Morning program

The morning session will provide an overview of HPV, its associated cancers, the safety and efficacy of the vaccine, and a presentation from a local Cervivor.

This session will conclude with interactive breakout sessions for advocates and health professionals, including how to talk with parents and students about vaccination and screenings with an emphasis on culturally competent and respectful conversations.

WHO SHOULD ATTEND - Patient advocates, oral health professionals, community health workers, medical assistants, students


Afternoon Session

12:30 p.m. - 1:00 p.m. - Registration
1:00 p.m. - 5:00 p.m. Afternoon program

The afternoon program will feature both a national and local perspective on HPV and the vaccine, as well as an interactive panel discussion with local experts providing clinical and community perspectives.

WHO SHOULD ATTEND - Anyone interested in the morning session plus medical providers, policymakers, public health professionals, and other interested HPV stakeholders.